US Military Service May Impact Risk of Certain Cancers
Researchers have found several differences in cancer rates between members of the US military and the general US population.
Diagnosis & Disease Information
Pembrolizumab Plus Chemoradiotherapy Under Review for High-Risk, Locally Advanced Cervical Cancer
Pembrolizumab plus chemoradiotherapy is under priority review for newly diagnosed, high-risk, locally advanced cervical cancer.
Mississippi’s Cervical Cancer Deaths Indicate Broader Health Care Problems
Mississippi had the nation’s second-highest age-adjusted cervical cancer mortality rate from 2016 through 2020.
NACT-S No Better Than CCRT for Stage IB2-IIB Cervical Cancer
Neoadjuvant chemotherapy followed by surgery is not superior to concomitant chemoradiotherapy for patients with stage IB2-IIB cervical cancer, phase 3 data suggest.
Antibody-Drug Conjugates Pose Risk of Ocular Adverse Effects
Pharmaceutical experts review ocular adverse effects related to antibody-drug conjugates.
Researchers Estimate Life-Years Gained From Cancer Screening
Screening for breast, colorectal, cervical, and lung cancer may have translated to as many as 16.2 million life-years gained in the US.
Family of Henrietta Lacks Files New Lawsuit Over HeLa Cells
The family of Henrietta Lacks has filed another in a series of planned lawsuits related to the HeLa cell line.
Biotech Company Settles With Family of Henrietta Lacks, Whose Cells Revolutionized Medicine
Henrietta Lacks’s cells were taken without her knowledge while she was a cancer patient more than 70 years ago.
Historical Redlining Adversely Impacts Cancer Screening
Historically redlined census tracts were significantly less likely to meet targets for breast, colon, and cervical cancer screening.
Cervical Cancer Screening Linked to Preterm Delivery
One additional recommended cervical cancer screening was associated with an increase in the risk of preterm delivery.
- Loading...
Loading...
Next post in Gynecologic Cancer
Loading... 
Loading...